Strong Biotechnologies secures four new medical device registrations

Beijing Strong Biotechnologies Co., Ltd. announced on October 10, 2025, that it has obtained four new medical device registration certificates from the Beijing Medical Products Administration. These new registrations include a urinary transferrin determination kit, a fibronectin determination kit, a copper determination kit, and another fibronectin determination kit.

The urinary transferrin determination kit is intended for quantitative determination of urinary transferrin (uTRF), while the fibronectin determination kits are for quantitative determination of fibronectin (FN) in human serum or plasma. The copper determination kit uses the PAESA colorimetric method for quantitative determination of copper (Cu) in human serum.

Two of the registered products, a fibronectin determination kit and a copper determination kit, are designated for use with Roche and Abbott instruments' closed-channel systems, respectively. The company expects these new registrations to enrich its product categories, enhance core competitiveness, and positively impact future development, although no significant impact on near-term production or performance is anticipated.